Fallopian tube cancer, a rare gynecologic cancer, is gaining awareness due to its potential origin for many high-grade serous ovarian cancers. New diagnostics improve early detection and treatment, ...

Discussion in Preimplantational Stages of Pregnancy, Ciba Foundation Symposium (edit. by Wolstenholme, G. E. W., and O'Connor, M.), 414 (Churchill Ltd. London, 1965 ...

Eligible patients can receive up to 70 per cent in subsidies for genetic tests, while MediShield Life coverage will be extended to selected risk-reducing surgical procedures.

Advances reimbursement strategy in the U.S. for FemaSeed, an intended first-step infertility treatment --ATLANTA, (GLOBE ...

Melbourne gynaecologist Dr Simon Gordon is under investigation by the medical regulator over allegations he performed unnecessary endometriosis surgeries on women.

SANTA CLARA, Calif., February 12, 2026--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced that the U.S. Food and Drug Administration (FDA) has approved PD-L1 IHC 22C3 pharmDx, Code ...

When Pamela Mactolo appeared on NTV’s Fixing the Nation on Feb 19, 2026, she didn’t expect the conversation to follow her ...

A prevention strategy developed by Canadian researchers can reduce the risk of the most common and deadly form of ovarian cancer by nearly 80 per cent, according to a new study published today ...

Morris, Nada Hassanein, Shalina Chatlani and Sofia Resnick, Wisconsin Examiner March 4, 2026 Editor’s note: This is ...

An AI tool to help doctors flag Healthier SG enrollees at high risk of chronic disease will also be rolled out Read more at The Business Times.

The Ministry of Health will expand MediShield Life to cover risk-reducing surgeries for hereditary breast and ovarian cancer and increase MediSave limits to support a super-aged population and enhance ...

FemBloc becomes the latest Femasys product to achieve MDSAP certification, building on a proven track record of compliance --ATLANTA, Feb.